Cerebral Small Vessel Disease: A Review Focusing on Pathophysiology, Biomarkers, and Machine Learning Strategies

다국어 초록 (Multilingual Abstract)

Cerebral small vessel disease (cSVD) has a crucial role in lacunar stroke and brain hemorrhages and is a leading cause of cognitive decline and functional loss in elderly patients. Based on underlying pathophysiology, cSVD can be subdivided into amyloidal and non-amyloidal subtypes.
Genetic factors of cSVD play a pivotal role in terms of unraveling molecular mechanism. An important pathophysiological mechanism of cSVD is blood-brain barrier leakage and endothelium dysfunction which gives a clue in identification of the disease through circulating biological markers. Detection of cSVD is routinely carried out by key neuroimaging markers including white matter hyperintensities, lacunes, small subcortical infarcts, perivascular spaces, cerebral microbleeds, and brain atrophy. Application of neural networking, machine learning and deep learning in image processing have increased significantly for correct severity of cSVD. A linkage between cSVD and other neurological disorder, such as Alzheimer’s and Parkinson’s disease and non-cerebral disease, has also been investigated recently. This review draws a broad picture of cSVD, aiming to inculcate new insights into its pathogenesis and biomarkers. It also focuses on the role of deep machine strategies and other dimensions of cSVD by linking it with several cerebral and non-cerebral diseases as well as recent advances in the field to achieve sensitive detection, effective prevention and disease management.

참고문헌 (Reference)

1 Pasi M, "White matter microstructural damage and depressive symptoms in patients with mild cognitive impairment and cerebral small vessel disease: the VMCI-Tuscany study" 31 : 611-618, 2016

2 Simpson JE, "White matter lesions in an unselected cohort of the elderly: astrocytic, microglial and oligodendrocyte precursor cell responses" 33 : 410-419, 2007

3 Rouhl RP, "Vascular inflammation in cerebral small vessel disease" 33 : 1800-1806, 2012

4 Gorelick PB, "Vascular contributions to cognitive impairment and dementia: a statement for healthcare professionals from the american heart association/american stroke association" 42 : 2672-2713, 2011

5 Thal DR, "Two types of sporadic cerebral amyloid angiopathy" 61 : 282-293, 2002

6 Pavlovic AM, "Transcranial parenchymal sonographic findings in patients with cerebral small vessel disease: a preliminary study" 34 : 1853-1859, 2015

7 Uiterwijk R, "Total cerebral small vessel disease MRI score is associated with cognitive decline in executive function in patients with hypertension" 8 : 301-, 2016

8 Wolburg H, "Tight junctions of the blood-brain barrier: development, composition and regulation" 38 : 323-337, 2002

9 Taylor WD, "The vascular depression hypothesis: mechanisms linking vascular disease with depression" 18 : 963-974, 2013

10 Pantoni L, "The relation between whitematter lesions and cognition" 20 : 390-397, 2007

11 Kirshner HS, "The inflammatory form of cerebral amyloid angiopathy or "cerebral amyloid angiopathy-related inflammation" (CAARI)" 15 : 54-, 2015

12 Charidimou A, "The concept of sporadic cerebral small vessel disease: a road map on key definitions and current concepts" 11 : 6-18, 2016

13 Hawkins BT, "The blood-brain barrier/neurovascular unit in health and disease" 57 : 173-185, 2005

14 Vogels SC, "The association of chronic kidney disease with brain lesions on MRI or CT: a systematic review" 71 : 331-336, 2012

15 Fisher CM, "The arterial lesions underlying lacunes" 12 : 1-15, 1968

16 Shi Z, "Survey on neural networks used for medical image processing" 3 : 86-100, 2009

17 Carey CL, "Subcortical lacunes are associated with executive dysfunction in cognitively normal elderly" 39 : 397-402, 2008

18 Zhang X, "Subclinical hypothyroidism and risk of cerebral small vessel disease: a hospital-based observational study" 87 : 581-586, 2017

19 Staals J, "Stroke subtype, vascular risk factors, and total MRI brain small-vessel disease burden" 83 : 1228-1234, 2014

20 Araki T, "Stroke risk stratification and its validation using ultrasonic echolucent carotid wall plaque morphology: a machine learning paradigm" 80 : 77-96, 2017

21 Centers for Disease Control and Prevention, "Stroke facts"

22 Charidimou A, "Sporadic cerebral amyloid angiopathy revisited: recent insights into pathophysiology and clinical spectrum" 83 : 124-137, 2012

23 McMurtray A, "Smallvessel vascular disease in human immunodeficiency virus infection: the Hawaii aging with HIV cohort study" 24 : 236-241, 2007

24 Nestor SM, "Small vessel disease is linked to disrupted structural network covariance in Alzheimer's disease" 13 : 749-760, 2017

25 Szpak GM, "Small cerebral vessel disease in familial amyloid and non-amyloid angiopathies: FAD-PS-1 (P117L) mutation and CADASIL. Immunohistochemical and ultrastructural studies" 45 : 192-204, 2007

26 Kurz DJ, "Simple point-of-care risk stratification in acute coronary syndromes: the AMIS model" 95 : 662-668, 2009

27 Hattori Y, "Silent information regulator 2 homolog 1 counters cerebral hypoperfusion injury by deacetylating endothelial nitric oxide synthase" 45 : 3403-3411, 2014

28 Vermeer SE, "Silent brain infarcts: a systematic review" 6 : 611-619, 2007

29 Gattringer T, "Serum neurofilament light is sensitive to active cerebral small vessel disease" 89 : 2108-2114, 2017

30 De Reuck J, "Seizures and epilepsy in patients with lacunar strokes" 263 : 75-78, 2007

31 Gould DB, "Role of COL4A1 in small-vessel disease and hemorrhagic stroke" 354 : 1489-1496, 2006

32 Worm SW, "Risk of myocardial infarction in patients with HIV infection exposed to specific individual antiretroviral drugs from the 3 major drug classes: the data collection on adverse events of anti-HIV drugs (D:A:D) study" 201 : 318-330, 2010

33 Rasmussen LD, "Risk of cerebrovascular events in persons with and without HIV: a Danish nationwide population-based cohort study" 25 : 1637-1646, 2011

34 Khan U, "Risk factor profile of cerebral small vessel disease and its subtypes" 78 : 702-706, 2007

35 Gonzalez-Castro V, "Reliability of an automatic classifier for brain enlarged perivascular spaces burden and comparison with human performance" 131 : 1465-1481, 2017

36 Maxwell H, "Prevalence and subtypes of radiological cerebrovascular disease in late-onset isolated seizures and epilepsy" 115 : 591-596, 2013

37 Ciulli S, "Prediction of impaired performance in trail making test in MCI patients with small vessel disease using DTI data" 20 : 1026-1033, 2016

38 Rufa A, "Plasma levels of asymmetric dimethylarginine in cerebral autosomal dominant arteriopathy with subcortical infarct and leukoencephalopathy" 26 : 636-640, 2008

39 Aono Y, "Plasma fibrinogen, ambulatory blood pressure, and silent cerebrovascular lesions: the Ohasama study" 27 : 963-968, 2007

40 Gurol ME, "Plasma beta-amyloid and white matter lesions in AD, MCI, and cerebral amyloid angiopathy" 66 : 23-29, 2006

41 Saba L, "Plaque tissue morphology-based stroke risk stratification using carotid ultrasound: a polling-based PCA learning paradigm" 41 : 98-, 2017

42 van Swieten JC, "Periventricular lesions in the white matter on magnetic resonance imaging in the elderly. A morphometric correlation with arteriolosclerosis and dilated perivascular spaces" 114 : 761-774, 1991

43 Fazekas F, "Pathologic correlates of incidental MRI white matter signal hyperintensities" 43 : 1683-1689, 1993

44 Song IU, "Parkinson's disease might increase the risk of cerebral ischemic lesions" 14 : 319-322, 2017

45 Takeuchi M, "Novel risk assessment tool for immunoglobulin resistance in Kawasaki disease: application using a random forest classifier" 36 : 821-826, 2017

46 Joutel A, "Notch3 mutations in CADASIL, a hereditary adult-onset condition causing stroke and dementia" 383 : 707-710, 1996

47 Lieb JM, "Normal pressure hydrocephalus" 55 : 389-396, 2015

48 Muller K, "New insight Into the pathogenesis of cerebral small-vessel diseases" 48 : 520-527, 2017

49 Kolar GR, "Neuropathology and genetics of cerebroretinal vasculopathies" 24 : 510-518, 2014

50 Young VG, "Neuropathologic correlates of white matter hyperintensities" 71 : 804-811, 2008

51 Wardlaw JM, "Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration" 12 : 822-838, 2013

52 Kuriyama N, "Nationwide hospital-based survey of idiopathic normal pressure hydrocephalus in Japan: epidemiological and clinical characteristics" 7 : e00635-, 2017

53 Modinos G, "Multivariate pattern classification reveals differential brain activation during emotional processing in individuals with psychosis proneness" 59 : 3033-3041, 2012

54 Miwa K, "Multiple or mixed cerebral microbleeds and dementia in patients with vascular risk factors" 83 : 646-653, 2014

55 Goos JD, "Microbleeds relate to altered amyloid-beta metabolism in Alzheimer's disease" 33 : 1011.e1-1011.e9, 2012

56 Nakata-Kudo Y, "Microbleeds in Alzheimer disease are more related to cerebral amyloid angiopathy than cerebrovascular disease" 22 : 8-14, 2006

57 de Laat KF, "Microbleeds are independently related to gait disturbances in elderly individuals with cerebral small vessel disease" 42 : 494-497, 2011

58 Stehouwer CD, "Microalbuminuria and risk for cardiovascular disease: analysis of potential mechanisms" 17 : 2106-2111, 2006

59 Wardlaw JM, "Mechanisms of sporadic cerebral small vessel disease: insights from neuroimaging" 12 : 483-497, 2013

60 Markus HS, "Markers of endothelial and hemostatic activation and progression of cerebral white matter hyperintensities: longitudinal results of the Austrian Stroke Prevention Study" 36 : 1410-1414, 2005

61 Shen D, "Machine learning in medical imaging" 41 : 1-2, 2015

62 Than JCM, "Lung disease stratification using amalgamation of Riesz and Gabor transforms in machine learning framework" 89 : 197-211, 2017

63 Huisa BN, "Long-term blood-brain barrier permeability changes in Binswanger disease" 46 : 2413-2418, 2015

64 Ghafoorian M, "Location sensitive deep convolutional neural networks for segmentation of white matter hyperintensities" 7 : 5110-, 2017

65 Knottnerus IL, "Levels of heparin-releasable TFPI are increased in first-ever lacunar stroke patients" 78 : 493-498, 2012

66 Biesbroek JM, "Lesion location and cognitive impact of cerebral small vessel disease" 131 : 715-728, 2017

67 Brisset M, "Large-vessel correlates of cerebral small-vessel disease" 80 : 662-669, 2013

68 Laurent S, "Large and small artery crosstalk and recent morbidity-mortality trials in hypertension" 54 : 388-392, 2009

69 Fisher CM, "Lacunar strokes and infarcts: a review" 32 : 871-876, 1982

70 Wardlaw JM, "Lacunar stroke is associated with diffuse blood-brain barrier dysfunction" 65 : 194-202, 2009

71 Louis R Caplan, "Lacunar Infarction and Small Vessel Disease: Pathology and Pathophysiology" 대한뇌졸중학회 17 (17): 2-6, 2015

72 Bailey EL, "Is the spontaneously hypertensive stroke prone rat a pertinent model of sub cortical ischemic stroke? A systematic review" 6 : 434-444, 2011

73 Wardlaw JM, "Is breakdown of the blood-brain barrier responsible for lacunar stroke, leukoaraiosis, and dementia?" 34 : 806-812, 2003

74 Boulouis G, "Intracranial atherosclerosis and cerebral small vessel disease in intracerebral hemorrhage patients" 369 : 324-329, 2016

75 Love S, "Insights into the pathogenesis and pathogenicity of cerebral amyloid angiopathy" 14 : 4778-4792, 2009

76 Miwa K, "Increased total homocysteine levels predict the risk of incident dementia independent of cerebral smallvessel diseases and vascular risk factors" 49 : 503-513, 2016

77 Pinter D, "Impact of small vessel disease in the brain on gait and balance" 7 : 41637-, 2017

78 Lammie GA, "Hypertensive cerebral small vessel disease and stroke" 12 : 358-370, 2002

79 Kario K, "Hyperinsulinemia and hemostatic abnormalities are associated with silent lacunar cerebral infarcts in elderly hypertensive subjects" 37 : 871-877, 2001

80 Vermeer SE, "Homocysteine, silent brain infarcts, and white matter lesions: the Rotterdam Scan Study" 51 : 285-289, 2002

81 Sachdev P, "Homocysteine and the brain in midadult life: evidence for an increased risk of leukoaraiosis in men" 61 : 1369-1376, 2004

82 Kloppenborg RP, "Homocysteine and cerebral small vessel disease in patients with symptomatic atherosclerotic disease. The SMARTMR study" 216 : 461-466, 2011

83 Brundel M, "High prevalence of cerebral microbleeds at 7Tesla MRI in patients with early Alzheimer's disease" 31 : 259-263, 2012

84 Gomes J, "Handbook of Clinical Nutrition and Stroke" Springer 15-32, 2013

85 Iejima D, "HTRA1 (high temperature requirement A serine peptidase 1) gene is transcriptionally regulated by insertion/deletion nucleotides located at the 3' end of the ARMS2 (agerelated maculopathy susceptibility 2) gene in patients with age-related macular degeneration" 290 : 2784-2797, 2015

86 Soontornniyomkij V, "HIV protease inhibitor exposure predicts cerebral small vessel disease" 28 : 1297-1306, 2014

87 Morgello S, "HCV, but not HIV, is a risk factor for cerebral small vessel disease" 1 : e27-, 2014

88 Kitamura A, "Gradual cerebral hypoperfusion in spontaneously hypertensive rats induces slowly evolving white matter abnormalities and impairs working memory" 36 : 1592-1602, 2016

89 Feigin VL, "Global burden of stroke" 120 : 439-448, 2017

90 Jay Chol Choi, "Genetics of Cerebral Small Vessel Disease" 대한뇌졸중학회 17 (17): 7-16, 2015

91 Chen A, "Frontal white matter hyperintensities, clasmatodendrosis and gliovascular abnormalities in ageing and poststroke dementia" 139 : 242-258, 2016

92 Raposo N, "Florbetapir imaging in cerebral amyloid angiopathyrelated hemorrhages" 89 : 697-704, 2017

93 van der Holst HM, "Factors associated with 8-year mortality in older patients with cerebral small vessel disease: the Radboud University Nijmegen Diffusion Tensor and Magnetic Resonance Cohort (RUN DMC) study" 73 : 402-409, 2016

94 Hsu TR, "Fabry disease: review and experience during newborn screening" 28 : 274-281, 2018

95 Kuppili V, "Extreme learning machine framework for risk stratification of fatty liver disease using ultrasound tissue characterization" 41 : 152-, 2017

96 Bo Norrving, "Evolving Concept of Small Vessel Disease through Advanced Brain Imaging" 대한뇌졸중학회 17 (17): 94-100, 2015

97 Guo H, "Evaluation of common structural brain changes in aging and Alzheimer disease with the use of an MRI-based brain atrophy and lesion index: a comparison between T1WI and T2WI at 1.5T and 3T" 35 : 504-512, 2014

98 Huang X, "Evaluation of carotid artery elasticity changes in patients with cerebral small vessel disease" 8 : 18825-18830, 2015

99 Notsu Y, "Evaluation of asymmetric dimethylarginine and homocysteine in microangiopathy-related cerebral damage" 22 : 257-262, 2009

100 Armulik A, "Endothelial/pericyte interactions" 97 : 512-523, 2005

101 Rajani RM, "Endothelial cell-oligodendrocyte interactions in small vessel disease and aging" 131 : 369-379, 2017

102 Ihara M, "Emerging evidence for pathogenesis of sporadic cerebral small vessel disease" 47 : 554-560, 2016

103 Pasi M, "Distribution of lacunes in cerebral amyloid angiopathy and hypertensive small vessel disease" 88 : 2162-2168, 2017

104 Lyoubi-Idrissi AL, "Diffusion magnetic resonance imaging in cerebral small vessel disease" 173 : 201-210, 2017

105 Charidimou A, "Developing biomarkers for cerebral amyloid angiopathy trials: do potential disease phenotypes hold promise?" 13 : 538-540, 2014

106 Ghafoorian M, "Deep multi-scale location-aware 3D convolutional neural networks for automated detection of lacunes of presumed vascular origin" 14 : 391-399, 2017

107 LeCun Y, "Deep learning" 521 : 436-444, 2015

108 Rawat W, "Deep convolutional neural networks for image classification: a comprehensive review" 29 : 2352-2449, 2017

109 Fotiadis P, "Cortical atrophy in patients with cerebral amyloid angiopathy: a case-control study" 15 : 811-819, 2016

110 Rajashekhar G, "Continuous endothelial cell activation increases angiogenesis: evidence for the direct role of endothelium linking angiogenesis and inflammation" 43 : 193-204, 2006

111 Chow FC, "Comparison of ischemic stroke incidence in HIV-infected and non-HIV-infected patients in a US health care system" 60 : 351-358, 2012

112 Rannikmae K, "Common variation in COL4A1/COL4A2 is associated with sporadic cerebral small vessel disease" 84 : 918-926, 2015

113 Sahiner B, "Classification of mass and normal breast tissue: a convolution neural network classifier with spatial domain and texture images" 15 : 598-610, 1996

114 Kim Y, "Circulating matrix metalloproteinase-9 level is associated with cerebral white matter hyperintensities in non-stroke individuals" 72 : 234-240, 2014

115 Poggesi A, "Circulating biologic markers of endothelial dysfunction in cerebral small vessel disease: a review" 36 : 72-94, 2016

116 Satizabal CL, "Circulating IL-6 and CRP are associated with MRI findings in the elderly: the 3C-Dijon Study" 78 : 720-727, 2012

117 Tai SY, "Cilostazol as an add-on therapy for patients with Alzheimer's disease in Taiwan: a case control study" 17 : 40-, 2017

118 Lambert C, "Characterising the grey matter correlates of leukoaraiosis in cerebral small vessel disease" 9 : 194-205, 2015

119 van Opstal AM, "Cerebrovascular function in presymptomatic and symptomatic individuals with hereditary cerebral amyloid angiopathy: a case-control study" 16 : 115-122, 2017

120 Pantoni L, "Cerebrospinal fluid proteins in patients with leucoaraiosis: possible abnormalities in blood-brain barrier function" 115 : 125-131, 1993

121 de Laat KF, "Cerebral white matter lesions and lacunar infarcts contribute to the presence of mild parkinsonian signs" 43 : 2574-2579, 2012

122 Pantoni L, "Cerebral small vessel disease: from pathogenesis and clinical characteristics to therapeutic challenges" 9 : 689-701, 2010

123 Russo E, "Cerebral small vessel disease predisposes to temporal lobe epilepsy in spontaneously hypertensive rats" 130 : 245-250, 2017

124 Cho KH, "Cerebral small vessel disease in branch retinal artery occlusion" 57 : 5818-5824, 2016

125 van der Holst HM, "Cerebral small vessel disease and incident parkinsonism: the RUN DMC study" 85 : 1569-1577, 2015

126 van Sloten TT, "Cerebral small vessel disease and association with higher incidence of depressive symptoms in a general elderly population: the AGES-Reykjavik study" 172 : 570-578, 2015

127 Cai Z, "Cerebral small vessel disease and Alzheimer's disease" 10 : 1695-1704, 2015

128 Rosenblum WI, "Cerebral hemorrhage produced by ruptured dissecting aneurysm in miliary aneurysm" 54 : 376-378, 2003

129 Deplanque D, "Cerebral and extracerebral vasoreactivity in symptomatic lacunar stroke patients: a casecontrol study" 8 : 413-421, 2013

130 Vinters HV, "Cerebral amyloid angiopathy. A critical review" 18 : 311-324, 1987

131 Alessandro Biffi, "Cerebral Amyloid Angiopathy: A Systematic Review" 대한신경과학회 7 (7): 1-9, 2011

132 Tikka S, "CADASIL and CARASIL" 24 : 525-544, 2014

133 van Dijk EJ, "C-reactive protein and cerebral small-vessel disease: the Rotterdam Scan Study" 112 : 900-905, 2005

134 Starr JM, "Brain white matter lesions detected by magnetic resonance [correction of resosnance] imaging are associated with balance and gait speed" 74 : 94-98, 2003

135 Aribisala BS, "Brain atrophy associations with white matter lesions in the ageing brain: the Lothian Birth Cohort 1936" 23 : 1084-1092, 2013

136 Pescini F, "Bone marrow-derived progenitor cells in cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy" 41 : 218-223, 2010

137 Farrall AJ, "Blood-brain barrier: ageing and microvascular disease: systematic review and meta-analysis" 30 : 337-352, 2009

138 Topakian R, "Blood-brain barrier permeability is increased in normal-appearing white matter in patients with lacunar stroke and leucoaraiosis" 81 : 192-197, 2010

139 Zhang CE, "Blood-brain barrier leakage is more widespread in patients with cerebral small vessel disease" 88 : 426-432, 2017

140 Wardlaw JM, "Blood-brain barrier failure as a core mechanism in cerebral small vessel disease and dementia: evidence from a cohort study" 13 : 634-643, 2017

141 Bridges LR, "Blood-brain barrier dysfunction and cerebral small vessel disease (arteriolosclerosis) in brains of older people" 73 : 1026-1033, 2014

142 Aribisala BS, "Blood pressure, internal carotid artery flow parameters, and age-related white matter hyperintensities" 63 : 1011-1018, 2014

143 Fornage M, "Biomarkers of inflammation and MRI-defined small vessel disease of the brain: the cardiovascular health study" 39 : 1952-1959, 2008

144 Pavlovic AM, "Baseline predictors of cognitive decline in patients with cerebral small vessel disease" 42 (42): S37-S43, 2014

145 Kovacic JC, "Atherosclerotic risk factors, vascular cognitive impairment, and Alzheimer disease" 79 : 664-673, 2012

146 Kester MI, "Associations between cerebral small-vessel disease and Alzheimer disease pathology as measured by cerebrospinal fluid biomarkers" 71 : 855-862, 2014

147 Pikula A, "Association of plasma ADMA levels with MRI markers of vascular brain injury: Framingham offspring study" 40 : 2959-2964, 2009

148 Xu X, "Association of magnetic resonance imaging markers of cerebrovascular disease burden and cognition" 46 : 2808-2814, 2015

149 Hatate J, "Association between cerebral small vessel diseases and mild parkinsonian signs in the elderly with vascular risk factors" 26 : 29-34, 2016

150 Poels MM, "Arterial stiffness and cerebral small vessel disease: the Rotterdam Scan Study" 43 : 2637-2642, 2012

151 Kandimalla RJ, "Apo-E4 allele in conjunction with Abeta42 and tau in CSF: biomarker for Alzheimer's disease" 8 : 187-196, 2011

152 Lin HC, "An application of artificial immune recognition system for prediction of diabetes following gestational diabetes" 35 : 283-289, 2011

153 Farid K, "Amyloid positron emission tomography in sporadic cerebral amyloid angiopathy: a systematic critical update" 15 : 247-263, 2017

154 Klarenbeek P, "Ambulatory blood pressure in patients with lacunar stroke: association with total MRI burden of cerebral small vessel disease" 44 : 2995-2999, 2013

155 Georgakis MK, "Albuminuria and cerebral small vessel disease: a systematic review and meta-analysis" 66 : 509-517, 2018

156 Khalifa A, "Adapting existing natural language processing resources for cardiovascular risk factors identification in clinical notes" 58 (58): S128-S132, 2015

157 Litjens G, "A survey on deep learning in medical image analysis" 42 : 60-88, 2017

158 Papageorgiou EI, "A risk management model for familial breast cancer: a new application using Fuzzy Cognitive Map method" 122 : 123-135, 2015

159 Skoog I, "A population study on blood-brain barrier function in 85-year-olds: relation to Alzheimer's disease and vascular dementia" 50 : 966-971, 1998

160 Tay D, "A novel neural-inspired learning algorithm with application to clinical risk prediction" 54 : 305-314, 2015

161 Shrivastava VK, "A novel and robust Bayesian approach for segmentation of psoriasis lesions and its risk stratification" 150 : 9-22, 2017